Sartorius Appoints Life SciencesLeader

Sartorius has appointed Dominique Baly as President of the company’s Group Laboratory Business effective since January 1. The former Millipore executive has assumed crossdivisional management of marketing, sales and service for the business unit, reporting directly to the CEO, Dr Joachim Kreuzburg; he is also a member of the Group Executive Committee. The new management appointment is a seen as a key component in further strategic and operational development of its laboratory business. With the Bioprocess business’ significant rise in revenue and profit over the past years, the Executive Board is now increasing focus on the laboratory activities of both Group divisions and the appointment is seen as a key component of that process.

Dominique Baly joins Sartorius with more than 35 years of sales and managerial experience for Millipore Corporation, which was acquired by Merck KGaA in 2010. From 2005 to 2008, he was President of the $700 millions Bioscience Division. In2009, he became CEO of Accelerator Sciences LLC, a U.S. investment firm backed by private equity. Baly is of dual nationality, French and American, holds a degree as a pharmacist from the Louis Pasteur University in Strasbourg (France) and has lived and worked in Europe, Asia and the United States of America.